DK174831B1 - Farmaceutiske præparater indeholdende ergolin-derivatet pergolid og fremgangsmåde til stabiliseringaf sådanne præparater - Google Patents
Farmaceutiske præparater indeholdende ergolin-derivatet pergolid og fremgangsmåde til stabiliseringaf sådanne præparater Download PDFInfo
- Publication number
- DK174831B1 DK174831B1 DK198805831A DK583188A DK174831B1 DK 174831 B1 DK174831 B1 DK 174831B1 DK 198805831 A DK198805831 A DK 198805831A DK 583188 A DK583188 A DK 583188A DK 174831 B1 DK174831 B1 DK 174831B1
- Authority
- DK
- Denmark
- Prior art keywords
- pergolide
- polyvinylpyrrolidone
- pharmaceutically acceptable
- amount
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/112,360 US4797405A (en) | 1987-10-26 | 1987-10-26 | Stabilized pergolide compositions |
| US11236087 | 1987-10-26 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK583188D0 DK583188D0 (da) | 1988-10-20 |
| DK583188A DK583188A (da) | 1989-04-27 |
| DK174831B1 true DK174831B1 (da) | 2003-12-08 |
Family
ID=22343489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198805831A DK174831B1 (da) | 1987-10-26 | 1988-10-20 | Farmaceutiske præparater indeholdende ergolin-derivatet pergolid og fremgangsmåde til stabiliseringaf sådanne præparater |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4797405A (ja) |
| EP (1) | EP0314387B1 (ja) |
| JP (1) | JP2747303B2 (ja) |
| KR (1) | KR960013284B1 (ja) |
| AT (1) | ATE79258T1 (ja) |
| AU (1) | AU611494B2 (ja) |
| CA (1) | CA1318253C (ja) |
| DE (1) | DE3873688T2 (ja) |
| DK (1) | DK174831B1 (ja) |
| ES (1) | ES2042760T3 (ja) |
| GR (1) | GR3005784T3 (ja) |
| HU (1) | HU200691B (ja) |
| IE (1) | IE61960B1 (ja) |
| IL (1) | IL88087A (ja) |
| NZ (1) | NZ226650A (ja) |
| PH (1) | PH25575A (ja) |
| ZA (1) | ZA887805B (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114948A (en) * | 1989-10-19 | 1992-05-19 | Eli Lilly And Company | Stabilized pergolide compositions |
| US6572879B1 (en) * | 1995-06-07 | 2003-06-03 | Alza Corporation | Formulations for transdermal delivery of pergolide |
| DE19626621A1 (de) * | 1996-07-02 | 1998-01-08 | Hexal Ag | Pflaster zur transdermalen Anwendung von Pergolid |
| US6623752B1 (en) | 1996-07-02 | 2003-09-23 | Hexal Ag | Patch for transdermal application for pergolid |
| JP4610834B2 (ja) * | 1999-11-11 | 2011-01-12 | 杏林製薬株式会社 | 経口固形製剤 |
| HUP0303355A3 (en) | 2000-08-08 | 2005-06-28 | Teva Pharma | Stable pergolide mesylate and process for making same |
| DE10066158B4 (de) * | 2000-08-24 | 2007-08-09 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms |
| DE10053397A1 (de) * | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| DE10341317B4 (de) * | 2003-09-03 | 2008-10-23 | Axxonis Pharma Ag | Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid |
| US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
| DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| CN1649614A (zh) | 2002-02-22 | 2005-08-03 | 新河药品股份有限公司 | 活性剂传递系统和保护及施用活性剂的方法 |
| AU2003215461A1 (en) * | 2002-03-26 | 2003-10-08 | Bernard Charles Sherman | Stable tablets comprising pergolide mesylate |
| KR101302118B1 (ko) * | 2011-04-22 | 2013-08-30 | 한림대학교 산학협력단 | 단백질 수송 도메인과 치료용 단백질이 공유결합한 융합 단백질에 퍼골라이드를 가하여 융합 단백질의 생체 세포 또는 조직 내 도입을 증가시키는 방법 |
| US20190374534A1 (en) * | 2018-06-08 | 2019-12-12 | Boehringer Ingelheim Vetmedica Gmbh | Liquid pharmaceutical compositions comprising pergolide |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2680749A (en) * | 1951-12-01 | 1954-06-08 | Eastman Kodak Co | Water-soluble tocopherol derivatives |
| US3864469A (en) * | 1967-12-16 | 1975-02-04 | Hoechst Ag | Xanthines in pharmaceutical preparations and for stabilization of vitamins |
| US4473565A (en) * | 1976-05-13 | 1984-09-25 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
| JPS5399316A (en) * | 1977-02-04 | 1978-08-30 | Sanpo Seiyaku Kk | Stbilyzing method of leserpine preparation |
| AT362051B (de) * | 1977-04-05 | 1981-04-27 | Sandoz Ag | Verfahren zur herstellung von injektions- praeparaten |
| JPS542316A (en) * | 1977-06-07 | 1979-01-09 | Yamanouchi Pharmaceut Co Ltd | Solid pharmaceutical composition containing nifedipene |
| JPS5446837A (en) * | 1977-09-19 | 1979-04-13 | Kanebo Ltd | Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same |
| US4166182A (en) * | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
| US4202979A (en) * | 1979-01-11 | 1980-05-13 | Eli Lilly And Company | 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
| US4329366A (en) * | 1979-11-08 | 1982-05-11 | Johnson & Johnson Products, Inc. | Topical acylaminophenols |
| DE3136282A1 (de) * | 1981-09-12 | 1983-03-24 | Hoechst Ag | "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen" |
| JPS58105913A (ja) * | 1981-12-18 | 1983-06-24 | Nippon Chemiphar Co Ltd | ニフエジピン軟カプセル剤 |
| JPS58206533A (ja) * | 1982-05-27 | 1983-12-01 | Teijin Ltd | 活性型ビタミンｄ↓３誘導体組成物及びそれを活性成分とする薬剤 |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| JPS60155111A (ja) * | 1983-10-20 | 1985-08-15 | Hisamitsu Pharmaceut Co Inc | 安定なケトプロフェン含有外用経皮製剤 |
| DE3424553A1 (de) * | 1984-07-04 | 1986-01-09 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung |
| JPS6176416A (ja) * | 1984-09-20 | 1986-04-18 | Fujimoto Seiyaku Kk | 活性型ビタミンｄ↓３誘導体のカプセル剤用組成物 |
| JPS6270317A (ja) * | 1985-09-24 | 1987-03-31 | Sawai Seiyaku Kk | 活性型ビタミンｄ↓３類含有製剤 |
| DE3814521A1 (de) * | 1987-05-07 | 1988-11-17 | Sandoz Ag | Neue anwendung von dopaminrezeptor-agonisten |
-
1987
- 1987-10-26 US US07/112,360 patent/US4797405A/en not_active Expired - Lifetime
-
1988
- 1988-10-19 CA CA000580595A patent/CA1318253C/en not_active Expired - Fee Related
- 1988-10-19 ZA ZA887805A patent/ZA887805B/xx unknown
- 1988-10-19 IL IL88087A patent/IL88087A/xx not_active IP Right Cessation
- 1988-10-20 AT AT88309848T patent/ATE79258T1/de not_active IP Right Cessation
- 1988-10-20 DE DE8888309848T patent/DE3873688T2/de not_active Expired - Lifetime
- 1988-10-20 AU AU24080/88A patent/AU611494B2/en not_active Expired
- 1988-10-20 ES ES88309848T patent/ES2042760T3/es not_active Expired - Lifetime
- 1988-10-20 JP JP63267000A patent/JP2747303B2/ja not_active Expired - Lifetime
- 1988-10-20 DK DK198805831A patent/DK174831B1/da not_active IP Right Cessation
- 1988-10-20 NZ NZ226650A patent/NZ226650A/xx unknown
- 1988-10-20 HU HU885422A patent/HU200691B/hu unknown
- 1988-10-20 KR KR1019880013656A patent/KR960013284B1/ko not_active IP Right Cessation
- 1988-10-20 EP EP88309848A patent/EP0314387B1/en not_active Expired - Lifetime
- 1988-10-21 PH PH37714A patent/PH25575A/en unknown
- 1988-10-21 IE IE319988A patent/IE61960B1/en not_active IP Right Cessation
-
1992
- 1992-09-24 GR GR920402106T patent/GR3005784T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE883199L (en) | 1989-04-26 |
| KR960013284B1 (ko) | 1996-10-02 |
| ZA887805B (en) | 1990-06-27 |
| IL88087A (en) | 1992-09-06 |
| IL88087A0 (en) | 1989-06-30 |
| KR890006238A (ko) | 1989-06-12 |
| JP2747303B2 (ja) | 1998-05-06 |
| IE61960B1 (en) | 1994-11-30 |
| HUT48462A (en) | 1989-06-28 |
| EP0314387B1 (en) | 1992-08-12 |
| DK583188A (da) | 1989-04-27 |
| PH25575A (en) | 1991-08-08 |
| CA1318253C (en) | 1993-05-25 |
| ATE79258T1 (de) | 1992-08-15 |
| NZ226650A (en) | 1990-08-28 |
| AU2408088A (en) | 1989-04-27 |
| DK583188D0 (da) | 1988-10-20 |
| HU200691B (en) | 1990-08-28 |
| US4797405A (en) | 1989-01-10 |
| GR3005784T3 (ja) | 1993-06-07 |
| ES2042760T3 (es) | 1993-12-16 |
| AU611494B2 (en) | 1991-06-13 |
| JPH01146821A (ja) | 1989-06-08 |
| DE3873688T2 (de) | 1993-03-11 |
| EP0314387A1 (en) | 1989-05-03 |
| DE3873688D1 (de) | 1992-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK174831B1 (da) | Farmaceutiske præparater indeholdende ergolin-derivatet pergolid og fremgangsmåde til stabiliseringaf sådanne præparater | |
| US20220054474A1 (en) | Pharmaceutical formulations of a hif hydroxylase inhibitor | |
| EP1067927B1 (en) | Antioxidant stabilizer system for pharmaceutical formulations | |
| CA1297024C (en) | Drug compositions stabilized against oxidation | |
| US5114948A (en) | Stabilized pergolide compositions | |
| JP4551988B2 (ja) | ２−メチル−チエノ−ベンゾジアゼピン製剤 | |
| EP0448091B1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
| KR920006908B1 (ko) | 디히드로피리딘을 함유하는 고상 약제의 제조 방법 | |
| EP0264259B1 (en) | Stabilized pharmaceutical compositions | |
| DK159590B (da) | Fremgangsmaade til forhindring af nedbrydning af thieno-pyridinderivater | |
| US5266581A (en) | Solid composition containing dihydropyridine, PVP and PVPP | |
| US11072620B2 (en) | Crystalline forms of Ponatinib hydrochloride | |
| US4465692A (en) | Selective D-2 dopamine receptor agonist | |
| JP2001354566A (ja) | ニセルゴリンの錠剤 | |
| US3627886A (en) | Methods of solubilizing coumermycin employing urea, dimethylacetamide or mixtures thereof | |
| US20200317616A1 (en) | Crystalline Form of Betrixaban Maleate | |
| WO2023190283A1 (ja) | ポリオキシエチレン構造を含む油性成分を含有する化合物製剤 | |
| JP2684493B2 (ja) | 安定なテプレノン製剤 | |
| KR920005812B1 (ko) | 안정한 폴리프레닐계 화합물 | |
| EP0254068A2 (en) | Novel therapeutic agent for gastritis | |
| US5238946A (en) | Therapeutic agent for gastritis | |
| CZ203696A3 (en) | Dimaleate of n,n-diethyl-8,8-dipropyl-2-azaspiro£4,5|decane-2-propanamine, pharmaceutical composition containing thereof and the use of such compound | |
| US20160304477A1 (en) | Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals | |
| WO2019138424A1 (en) | Stable pharmaceutical compositions comprising lenalidomide | |
| WO2017035263A1 (en) | Compositions comprising a plasma kallikrein inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |